Benadryl Extra Strength Cream Recalled for Improper Storage Conditions
Family Dollar Stores is recalling Benadryl Extra Strength Cream 1 oz distributed from April 30 through June 10, 2022, because the product was held outside appropriate storage temperature conditions. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class II recall involves no reported illnesses or injuries, and the hazard—improper storage temperature during distribution—is theoretical without documented product contamination or degradation. This fits the profile of a precautionary manufacturing compliance recall.
Plain-English summary
Family Dollar Stores, LLC is recalling Benadryl Extra Strength Cream 1 oz (SKU 902163) distributed to specific Family Dollar Store locations nationwide between April 30, 2022, and June 10, 2022.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the product was held outside appropriate storage temperature conditions, which may have affected product quality and stability.
Consumers who purchased this cream from Family Dollar Stores during the specified timeframe should stop using it and discard or return the product to the point of purchase. Anyone with questions about their health or potential effects from using this product should contact their healthcare provider.
The recalled product
- Product
- BENADRYL EXTRA STRENGTH CREAM 1 OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Topical Cream
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 902163
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27